These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6085357)

  • 1. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a calcium channel blocker on cardiac output distribution in conscious hypertensive dogs.
    Knight DR; Kirby DA; Vatner SF
    Hypertension; 1985; 7(3 Pt 1):380-5. PubMed ID: 3158603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.
    Fouad FM; Aboul-Khair M; Tarazi RC
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.
    Levenson J; Simon AC; Bouthier J; Maarek BC; Safar ME
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):107S-113S. PubMed ID: 4027144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central and peripheral hemodynamic effects of nifedipine administered orally and sublingually in essential arterial hypertension].
    Levenson J; Simon AC; Bouthier JD; Maarek BC; Safar ME
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():33-9. PubMed ID: 3937504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
    Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and vasodilating effects of acute medroxalol, a new beta-blocker with beta-2-adrenergic receptor stimulation.
    Simon A; Levenson J; Bouthier J; Merli I
    J Pharmacol; 1986; 17(3):331-7. PubMed ID: 3795977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of sex and hypertension on the geometrical design of large arteries. Sexual differences in normal and hypertensive forearm arteries.
    Simon AC; Levenson J; Cambien F; Bouthier J
    J Clin Hypertens; 1987 Dec; 3(4):617-23. PubMed ID: 3330990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effect of labetalol on hypertensive brachial artery.
    Pithois-Merli IM; Cournot AX; Georges DR; Pappo M; Safar ME
    J Clin Hypertens; 1987 Dec; 3(4):479-86. PubMed ID: 3453384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A; Lasaridis A; Settas L
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.